Neuro-Oncology: The Podcast

PODCAST · health

Neuro-Oncology: The Podcast

Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.

  1. 133

    Neuro-Oncology Nugget: Phase 1/2 BT008NA Trial — Focused Ultrasound + Temozolomide for High-Grade Glioma

    Host/Interviewee: Shahad Abdulsahib, PhD Graduate, UT Health San Antonio Description: Shahad Abdulsahib discusses the phase 1/2 BT008NA clinical trial evaluating microbubble-enhanced transcranial focused ultrasound combined with temozolomide in patients with newly diagnosed high-grade glioma, with findings published in The Lancet Oncology in December 2025

  2. 132

    SNObound: Career description and advice from Dr. Ryan Cecchi in Neuropathology

    Podcast Host and Interviewee: Dr. Shreya Louis (host), Dr. Ryan Cecchi (interviewee)      Podcast Description:  Dr. Shreya Louis interview Dr. Ryan Cecchi on his career in academic neuropathology focusing on the path to neuro-pathology, interesting developments in the field, and advise for trainees interested in neuro-oncology and neuropathology 

  3. 131

    SNObound: Career description and advice from Dr. Ryan Cecchi in Neuropathology

    Podcast Host and Interviewee: Dr. Shreya Louis (host), Dr. Ryan Cecchi (interviewee)    Podcast Description:  Dr. Shreya Louis interview Dr. Ryan Cecchi on his career in academic neuropathology focusing on the path to neuro-pathology, interesting developments in the field, and advise for trainees interested in neuro-oncology and neuropathology

  4. 130

    CATNON Conclusion: Closure on concurrent chemotherapy in IDHmt Grade 3 Astrocytoma

    Podcast Host and Interviewee: Host: Franziska Ippen Interviewee: David Schiff   Podcast Description:  Dr. Franziska Ippen interviews Dr. David Schiff on his recent manuscript entitled "CATNON Conclusion: Closure on concurrent chemotherapy in IDHmt Grade 3 Astrocytoma"

  5. 129

    Hot Topics: What's next in neuro-oncology

    Podcast Host and Interviewee: Host: Dr. Dave Rogawski Interviewee: Dr. Fabio Iwamoto Dr. Dave Rogawski interviews Dr. Fabio Iwamoto, incoming Neuro-Oncology Division Chief at Stanford, about where we're headed in neuro-oncology.  

  6. 128

    Neuro-Oncology Nugget: Career Development Outreach from SNO

    Podcast Host and Interviewee: Evan Noch, Producer, Neuro-oncology: The Podcast Podcast Description: Evan Noch discusses recent career development outreach from SNO

  7. 127

    Neuro-onc Narratives: An Interview with Caroline Catlin

    Podcast Host and Interviewee:  Host: Sara Hardy;  Interviewee: Caroline Catlin   Caroline Catlin is an artist and also a brain tumor survivor. Her writing and photography can be found in The New York Times, Longreads, Huffington Post, Glamour, and elsewhere. She has an MFA in Writing from Pacific University and a forthcoming memoir in progress, represented by Neon Literary.   Her TED talk, Why I Photograph the Quiet Moments of Grief and Loss, has been viewed over 1 million times. In this interview, she talks about how her diagnosis changed her life and how her art helped her to cope and thrive.

  8. 126

    Author Interview: "DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma"

    Podcast Host and Interviewee:  Host: John Fortunato Interviewee: Bob Jenkins  Podcast Description: Dr. John Fortunato interviews Dr. Bob Jenkins on his recent manuscript, titled "DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytoma."

  9. 125

    Hot Topics: AYA in Neuro-Oncology

    Dr. Dave Rogawski interviews Dr. Mary Jane (MJ) Lim-Fat and Dr. Kee Kiat (Aaron) Yeo on patient care and research for the adolescent and young adult (AYA) population in neuro-oncology.

  10. 124

    Neuro-Oncology Nugget: Bivalent EGFR/IL13Rα2 CAR T Cells for Recurrent Glioblastoma

    Shahad Abdulsahib discusses a phase 1 clinical trial of intracerebroventricular bivalent EGFR and IL13Rα2 CAR T cells for recurrent glioblastoma, published in Nature Medicine.

  11. 123

    SNObound: Career Advice from Dr. Brooke Braman in Radiation Oncology

    Jayden Hang and Dr. Michael Dohopolski interview Dr. Brooke Braman about her training path as a radiation oncology resident.

  12. 122

    Author Interview: Global analysis of clinical trials for children and adolescents with CNS tumors

     In this episode of Author Interviews, Dr. Jiasen He speaks with Dr. Margit K. Mikkelsen and Dr. Daniel C. Moreira from St. Jude Children's Research Hospital about their article, "Global Analysis of Clinical Trials for Children and Adolescents with CNS Tumors," published in Neuro-Oncology Pediatrics.

  13. 121

    Neuro-Oncology Nugget: Intracerebroventricular B7-H3 CAR T Cells for DIPG

    Shahad Abdulsahib discusses a phase 1 clinical trial of intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma, published in Nature Medicine in January 2025.

  14. 120

    Neuro-onc Narratives: Advocating for patient well-being in neuro-oncology

    Dr. Sara Hardy interviews Drs. Ashlee Loughan and Sarah Brahn to talk about their groundbreaking work to improve quality of life for patients with brain tumors.

  15. 119

    Author Interview: Visual morbidity, long-term outcome, and prognostic factors in infants and young children with optic pathway low-grade glioma

    Dr. John Fortunato interviews Dr. Stefania Picariello and Dr. Enrico Opocher on their manuscript, entitled "Visual morbidity, long-term outcome, and prognostic factors in infants and young children with optic pathway low-grade glioma."

  16. 118

    Hot Topics: Clinician-Patient Relationship in Neuro-Oncology

     Dr. Dave Rogawski interviews Dr. Akanksha Sharma on how we can optimize the meaningful, longitudinal relationships that drew many of us to the field.

  17. 117

    Neuro-Oncology Nugget: Targeted Radiotherapy Using Rhenium-186 Nanoliposomes for Recurrent Glioma

    Podcast Host and Interviewee: Shahad Abdulsahib, PhD Candidate, UT Health San Antonio Podcast Description: Shahad Abdulsahib discusses a recent Phase 1 clinical trial on Rhenium-186 nanoliposome therapy for recurrent glioma, published in Nature Communications in March 2025.

  18. 116

    SNObound: Career Advice from Dr. Gelareh Zadeh

    Dr. Alex Landry interviews Dr. Gelareh Zadeh on her career in academic neurosurgical oncology, focusing on the role of mentorship, how the field has evolved over time, and advice for junior trainees entering the field.   

  19. 115

    Author Interview: Ibrutinib for newly diagnosed primary CNS lymphoma

    Dr. Maya Graham interviews Dr. Lauren Schaff on her manuscript entitled "Ibrutinib in combination with rituximab, methotrexate, vincristine, and procarbazine (R-MVP/i) for newly diagnosed primary CNS lymphoma (PCNSL)," published in Neuro-Oncology in January 2026.

  20. 114

    Hot Topics: Radiation Hypofractionation in Glioma

    Dr. Nathan Dalton interviews Dr. Joseph Sia on the topic of radiation hypofractionation – its history, current clinical landscape, and potential future developments for patients with gliomas.

  21. 113

    Neuro-Oncology Nugget: Targeting CDK8 in MYC-Driven Medulloblastoma

    Shahad Abdulsahib discusses the findings of a recent paper, entitled "Transcriptional regulation of protein synthesis by mediator kinase represents a therapeutic vulnerability in MYC-driven medulloblastoma", which was published in Nature Communications in December 2025.

  22. 112

    Neuro-Onc Narratives: Patient Services at the American Brain Tumor Association

    Dr. Rachna Malani interviews Mindy Freund about her work at the American Brain Tumor Association

  23. 111

    Author Interview: Post-irradiation chemotherapy in patients with newly diagnosed ependymoma

    Dr. Jasmin Jo interviews Dr. Amy Smith and Dr. David Ellison on their manuscript, entitled "Phase 3 randomized trial of post-irradiation chemotherapy in patients with newly diagnosed ependymoma, a report from the Children's Oncology Group" published in Neuro-Oncology in December 2025.

  24. 110

    Hot Topics: How longitudinal profiling of glioma informs therapy development

    Dr. Dave Rogawski interviews Dr. David Solomon on his research that sheds light on how key genomic alterations in high-grade glioma evolve over time and how these insights might inform therapeutic development.

  25. 109

    Neuro-oncology Nugget: Microbubble-enhanced transcranial focused ultrasound with temozolomide for patients with high-grade glioma

    Dr. Haseeb Mehmood discusses the use of microbubble-enhanced transcranial focused ultrasound combined with standard temozolomide in high-grade glioma.

  26. 108

    SNObound: Career Advice from Neuro-oncologist, Dr. Lisa DeAngelis

    Dr. Evan Noch interviews Dr. Lisa DeAngelis about her career in neuro-oncology, role as Chair of Neurology and Physician-in-Chief at Memorial Sloan Kettering Cancer Center, and advice for trainees entering the field.

  27. 107

    Author Interview: Pamiparib and TMZ in recurrent IDHmt gliomas

    Dr. Iyad Alnahhas interviews Drs. David Schiff and Ranjit Bindra about their recent manuscript entitled "Phase I/II and Window-of-Opportunity Study of Pamiparib and Metronomic Temozolomide for Recurrent IDH Mutant Gliomas", published online in Neuro-Oncology in October 2025.

  28. 106

    Introduction to Neuro-Oncology: The Podcast 2.0

    In this episode, Dr. Evan Noch and Dr. Maya Graham discuss the exciting new podcast subtypes and the episodes to come.

  29. 105

    Radiotherapy induced neurocognitive decline

    Description: Dr. Iyad Alnahhas interviews Dr. Charlotte Sleurs about her and her team's recent manuscript entitled: "Radiotherapy-induced neurocognitive decline among adult intracranial tumor patients: A voxel-based approach", published online in Neuro-Oncology in May 2025.

  30. 104

    QOL and cognitive functioning in patients with oligodendroglioma

    Dr. Iyad Alnahhas interviews Drs. Florien Boele and Martin Klein about their recent manuscript entitled: "Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: An international cross-sectional investigation", published online in Neuro-Oncology in July 2025.

  31. 103

    Post-operative radiation in recurrent grade 1 meningiomas

    Dr. Iyad Alnahhas interviews Drs. Felix Sahm and Maximilian Deng about their recent manuscript entitled: "Postoperative radiotherapy in subtotally-resected recurrent WHO grade 1 meningiomas with intermediate/ high-risk molecular profiles", published online in Neuro-Oncology in May 2025.

  32. 102

    mRNA CAR T against GD2 in high-grade glioma models

    Dr. Maya Graham interviews Dr. Jessica Foster about her and her team's recent manuscript, entitled "Transient mRNA CAR T cells targeting GD2 provide dose-adjusted efficacy against diffuse midline glioma and high-grade glioma models". This work was published online in Neuro-Oncology in May 2025.

  33. 101

    A transcriptomic atlas of CNS tumors

    Dr. Evan Noch interviews Dr. Akshitkumar Mistry about his and his team's recent manuscript entitled "A clinically annotated transcriptomic atlas of nervous system tumors", published online in Neuro-Oncology in May 2025 Link to the paper: https://academic.oup.com/neuro-oncology/advance-article/doi/10.1093/neuonc/noaf130/8151442

  34. 100

    Gut microbiome in primary CNS lymphoma

    Dr. Iyad Alnahhas interviews Drs. Isaias Hernandez-Verdin and Agusti Alentorn about their recent manuscript entitled: "Gut microbiome modulates the outcome in primary central nervous system lymphoma patients undergoing chemotherapy: An ancillary study from the BLOCAGE trial", published online in Neuro-Oncology in March 2025   Link: https://academic.oup.com/neuro-oncology/advance-article/doi/10.1093/neuonc/noaf059/8058778

  35. 99

    Germline analysis of diffuse midline glioma

    Dr. Evan Noch interviews Dr. Marion Mateos about her and her team's recent manuscript entitled: "Germline analysis of an international cohort of pediatric diffuse midline glioma patients", published online in Neuro-Oncology in March 2025.

  36. 98

    The proteomic landscape of diffuse midline glioma

    Dr. Iyad Alnahhas interviews Drs. Cynthia Hawkins and Arun Vadivel about their recent manuscript entitled: "The proteomic landscape of diffuse midline glioma highlights the therapeutic potential of non-histone protein methyltransferases", published online in Neuro-Oncology in February 2025.   More Information

  37. 97

    Radio-Pathomic maps and MR perfusion

    Dr. Iyad Alnahhas interviews Dr. Peter LaViolette about his and his team's recent manuscript entitled: "Multi-Site Retrospective Analysis of Diffusion and Perfusion MRI Correlates to Glioma Characteristics Derived from Radio-Pathomic Maps", published online in Neuro-Oncology in February 2025.

  38. 96

    CSF proteomics in glioma

    Description: Dr. Evan Noch interviews Drs. Cecile Riviere-Cazaux and Terry Burns about their recent manuscript entitled: "A field resource for the glioma cerebrospinal fluid proteome: impacts of resection and location on biomarker discovery", published online in Neuro-Oncology in December 2024.   Link: https://doi.org/10.1093/neuonc/noae277  

  39. 95

    Vorasidenib in IDH mutant glioma

    Description: Dr. Ankush Bhatia interviews Drs. Macarena de la Fuente and Mehdi Touat about their recent manuscript entitled: "The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma" published online in Neuro-Oncology in December 2024.   Link: https://doi.org/10.1093/neuonc/noae259

  40. 94

    KL-50 in post TMZ MMR-deficient GBM

    Dr. Iyad Alnahhas interviews Dr. Craig Horbinski about his and his team's recent manuscript entitled "The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma", published online in Neuro-Oncology in December 2024.

  41. 93

    Measurable disease per FET-PET vs MRI in GBM

    Dr. Iyad Alnahhas interviews Dr. Nathalie Albert about her and her team's recent manuscript entitled: "Measurable disease as baseline criterion for response in glioblastoma: A comparison of PET-based (PET RANO 1.0) and MRI-based (RANO) assessments", published online in Neuro-Oncology in January 2025.

  42. 92

    Pre-radiation chemotherapy in GBM

    Dr. Iyad Alnahhas interviews Dr. Danielle Bazer about her and her team's recently published manuscript, entitled: Using a Pre-Radiation Window to Identify Potentially Active Cytotoxic Agents in Adults with Newly Diagnosed Glioblastoma", published online in Neuro-Oncology in November 2024.

  43. 91

    cIMPACT-NOW Update 8: grading of meningiomas

    Dr. Rachna Malani interviews Drs. Felix Sahm and Arie Perry about their recent manuscript entitled: "cIMPACT-NOW Update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas", published online in Neuro-Oncology in August 2024   Read More

  44. 90

    Residual tumor volume and survival after CCNU/TMZ in GBM

    Dr. Iyad Alnahhas interviews Drs. Thomas Zeyen and Johannes Weller about their recent manuscript entitled: "Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ", published online in Neuro-Oncology in October 2024.

  45. 89

    Alterations in RNA splicing between meningioma DNA methylation groups

    Dr. Evan Noch interviews Drs. Nathan Leclair, David Raleigh and Olga Anczukow about their recent manuscript entitled: "RNA splicing as a biomarker and phenotypic driver of meningioma DNA methylation groups", published online in Neuro-Oncology in August 2024.  

  46. 88

    The immune landscape of IDH mutant and IDHwt glioma

    Dr. Evan Noch interviews Drs. Pravesh Gupta and Krishna Bhat about their recent manuscript entitled "Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas", published online in Neuro-Oncology in August 2024 Read Paper

  47. 87

    Equity-driven applications of AI in neuro-oncology

    Dr. Iyad Alnahhas interviews Dr. Mulki Mehari about her and her team's recent manuscript entitled: "Enhancing neuro-oncology care through equity-driven applications of artificial intelligence", published online in Neuro-Oncology in August 2024.

  48. 86

    IDH mutant glioma across age groups

    Dr. Maya Graham interviews Drs. Mary Jane Lim-Fat and Kee Kiat Yeo about their recent manuscript entitled "A comparative analysis of IDH-mutant glioma in pediatric, young adult, and older adult patients", published online in Neuro-Oncology in July 2024. Link: https://doi.org/10.1093/neuonc/noae142

  49. 85

    Contemporary molecular prognostic signatures in glioma

    Dr. Iyad Alnahhas interviews Dr. Linda Bi, Hia Ghosh and Ruchit Patel about their recent manuscript entitled: "Contemporary Prognostic Signatures and Refined Risk Stratification of Gliomas: An Analysis of 4400 Tumors", published online in Neuro-Oncology in August 2024. More Information: https://academic.oup.com/neuro-oncology/advance-article/doi/10.1093/neuonc/noae164/7737688

  50. 84

    FDG PET in PCNSL

    Dr. Iyad Alnahhas interviews Drs. Minyoung Oh and Hyungwoo Cho about their recent manuscript entitled: "Enhancing Prognostication and Treatment Response Evaluation in Primary CNS Lymphoma with 18F-FDG PET/CT", published online in Neuro-Oncology in August 2024.   Link to manuscript

Type above to search every episode's transcript for a word or phrase. Matches are scoped to this podcast.

Searching…

No matches for "" in this podcast's transcripts.

Showing of matches

No topics indexed yet for this podcast.

Loading reviews...

ABOUT THIS SHOW

Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.

HOSTED BY

Neuro-Oncology

URL copied to clipboard!